[HTML][HTML] Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+ CD25+ regulatory T cells

X Ren, F Ye, Z Jiang, Y Chu, S Xiong… - Cell Death & …, 2007 - nature.com
X Ren, F Ye, Z Jiang, Y Chu, S Xiong, Y Wang
Cell Death & Differentiation, 2007nature.com
Abstract CD4+ CD25+ regulatory T cells (Treg) are potent immunosuppressive cells active in
controlling normal pathological immune responses. The mechanisms of this suppression
have been investigated under various conditions. In this report, tumor necrosis factor-related
apoptosis inducing ligand (TRAIL)/death receptor 5 (DR5) was explored as one of the
pivotal factors for the suppression and cytotoxicity induced by CD4+ CD25+ Treg. Cell death
was involved in the suppression induced by activated CD4+ CD25+ Treg in vitro. The …
Abstract
CD4+ CD25+ regulatory T cells (Treg) are potent immunosuppressive cells active in controlling normal pathological immune responses. The mechanisms of this suppression have been investigated under various conditions. In this report, tumor necrosis factor-related apoptosis inducing ligand (TRAIL)/death receptor 5 (DR5) was explored as one of the pivotal factors for the suppression and cytotoxicity induced by CD4+ CD25+ Treg. Cell death was involved in the suppression induced by activated CD4+ CD25+ Treg in vitro. The induction of CD4+ T cell death was not mediated by the CD95/CD95L pathway, but rather depended upon the upregulation of TRAIL in the Treg. Blocking the TRAIL/DR5 pathway resulted in a significant reduction of the suppressive activity as well as the cytotoxic effects of Treg in vitro. Activated Treg displayed TRAIL-dependent cytotoxicity against CD4+ T cells in vivo. The prolonged survival of allogeneic skin grafts induced by Treg was inhibited by DR5-blocking antibodies. Our findings suggest that the TRAIL/DR5 pathway is one of the mechanisms used by Treg to regulate immune responses both in vitro and in vivo.
nature.com